期刊文献+

硫化氢抑制丙酮醛诱导的人皮肤角质形成细胞损伤

Hydrogen sulfide attenuates methylglyoxal-induced human skin keratinocytes injury
原文传递
导出
摘要 目的 观察硫化氢(H2S)对丙酮醛(MGO)诱导的人皮肤角质形成细胞(HaCaT)损伤的影响.方法 HaCaT细胞分为MGO组、对照组和MGO+NSHD(H2S供体)组.MGO组用200、400、600 μmol/LMGO处理HaCaT细胞48 h造成细胞损伤;对照组给予等体积培养基;MGO+NSHD组应用400 μmol/LMGO处理,48 h前用50、100、200μmol/LNSHD预处理1h.通过CCK-8检测各组细胞活性.HaCaT细胞经100 μmol/LNSHD预处理1h,用20 μmol/L的H2S荧光探针WSP-1染色结合荧光照相术检测NSHD预处理1h组和对照组培养基和细胞内的H2S含量.将HaCaT细胞分为MGO组、MGO+NSHD组、NSHD组和对照组.MGO组仅用400 μmol/L MGO处理48 h;MGO+NSHD组在400 μmol/L MGO处理48 h前用100 μmol/L NSHD预处理1 h;NSHD组的细胞仅用100 μmol/L NSHD处理1h;对照组则给予等体积培养基.Hoechst 33258核染色结合荧光照相术检测细胞凋亡.Rh123染色结合荧光照相术检测线粒体膜电位(MMP).结果 HaCaT细胞经200、400和600 μmol/L MGO处理48 h,细胞活性依次为0.325±0.023、0.224±0.009和0.095±0.102,均低于对照组0.415±0.031(F=37.866,P<0.05),其中400 μmol/LMGO组细胞活性约为对照组的1/2,选用此浓度的MGO作为有效损伤浓度.100 μmol/L NSHD处理1h可使培养基和细胞内的H2S含量较对照组均增加.在400μmol/L MGO处理48 h前,分别用50、100和200 μnol/L NSHD预处理1h,细胞活性依次为0.235±0.028、0.314±0.017、0.346±0.020,均高于单独400μmol/L MGO处理组0.224±0.009(F=61.209,P<0.05).400 μmol/L MGO处理48 h后细胞凋亡率高于对照组和NSHD组[(32.6±3.5)%比(5.1±1.2)%、(3.4±0.8)%,均P<0.05],MMP低于对照组和NSHD组(28.5±2.9比46.1±3.8、48.6±4.3,均P<0.05).MGO+ NSHD组细胞凋亡率(18.3±2.6)%,低于MGO组但高于对照组和NSHD组(均P<0.05),MMP为38.9±3.2,高于MGO组但低于对照组和NSHD组(均P<0.05).结论 NSHD能通过释放H2S拮抗MGO诱导的皮肤细胞损伤. Objective To investigate the effects of hydrogen sulfide (H2S) on methylglyoxal (MGO)-induced human skin keratinocytes (HaCaT cells) injury.Methods HaCaT cells were assigned to control group,MGO group and MGO+NSHD(H2S donor) group.The MGO group was treated with 200,400 and 600 μmol/L MGO for 48 h to induce cell injury.Control group was treated with an aliquot of plain culture medium.In the MGO +NSHD group,before treatment with 400 μmol/L MGO for 48 h,the cells were preconditioned with 50,100 and 200 μmol/L NSHD for 1 h to examine the protective effects of H2S according to cell viability as measured by cell counting kit 8.After treatment with 100 μmol/L NSHD for 1 h,the levels of H2S in medium and cells of NSHD and control groups were assayed with 20 μmol/L WSP-1,the H2S fluorescent probe,for photofluorography.HaCaT cells were assigned to control group,MGO group,NSHD group and MGO+NSHD group.The MGO group was treated with 400 μmol/L MGO for 48 h to induce cell injury.Control group was treated with an aliquot of plain culture medium.In the MGO+NSHD group,before treatment with 400 μmol/L MGO for 48 h,the cells were preconditioned with 100 μmol/L NSHD,NSHD group was treated with only 100 μmol/L NSHD for 1 h.Cellular apoptosis and mitochondrial membrane potential (MMP) were observed by Hoechst 33258 and Rh123 staining followed by photofluorography respectively.Results Treatment with 200,400 and 600 μmol/L MGO for 48 h,were attenuated HaCaT cell viability 0.325±0.023,0.224±0.009 and 0.095±0.102 compared with control group 0.415±0.031 (F=37.866,P < 0.05).Both in medium and in cells of NSHD group,the content of H2S was enhanced after treatment with 100 μmol/L NSHD for 1 h compared with control group.The viability in 400 μmol/L MGO treatment for 48 h group was halved compared with control group,and therefore 400 μmol/L was deemed the optimal concentration for MGO treatment.Before treatment with 400 μtmol/L MGO for 48 h,the cells were preconditioned with 50,100 and 200 μmol/L NSHD for 1 h,with the viability being 0.235±0.028,0.314± 0.017 and 0.346±0.020 respectively,There were higher than that in the individual 400 μmol/L MGO group (F=61.209,P < 0.05).Compared with control and NSHD groups,The treatment with 400 μmol/L MGO for 48 h increased the apoptotic rate from (5.1±1.2)%,(3.4±0.8)% to (32.6±3.5)%,and decreased the MMP from 46.1±3.8,48.6±4.3 to 28.5±2.9 (all P<0.05).Prior to treatment with 400 μmol/L MGO for 48 h in the presence of preconditioning with 100 μmol/L NSHD for 1 h,the apoptotic rate was decreased to (18.3±2.6)% and the MMP was increased to 38.9±3.2.The apoptotic rate in MGO+NSHD group was lower than that in MGO group but higher than those in control group and NSHD group.The MMP in MGO+NSHD group was higher than that in MGO group but lower than those in control group and NSHD group (all P<0.05).Conclusion NSHD protects human skin keratinocytes from MGO-induced injury via release of H2S.
出处 《中华生物医学工程杂志》 CAS 2014年第4期263-267,共5页 Chinese Journal of Biomedical Engineering
基金 国家自然科学基金(81200606) 广东省科技计划项目(20128031800313)
关键词 糖尿病 硫化氢 角朊细胞 丙酮醛 皮肤溃疡 Diabetes H2S Keratinocytes Methylglyoxal Skin ulcer
  • 相关文献

参考文献14

  • 1Thornalley PJ.Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease[J].Drug Metabol Drug Interact,2008,23:125-150.
  • 2Zhu P,Yang C,Chen LH,et al.Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA[J].Arch Dermatol Res,2011,303:339-350.
  • 3Beisswenger PJ,Howell SK,Touchette AD,et al.Metformin reduces systemic methylglyoxal levels in type 2 diabetes[J].Diabetes,1999,48:198-202.
  • 4Dyer DG,Dunn JA,Thorpe SR,et al.Accumulation of Maillard reaction products in skin collagen in diabetes and aging[J].J Clin Invest,1993,91:2463-2469.
  • 5Jain SK,Bull R,Rains JL,et al.Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation[J]? Antioxid Redox Signal,2010,12:1333-1337.
  • 6Untereiner AA,Dhar A,Liu J,et al.Increased renal methylglyoxal formation with down-regulation of PGC-1 α-FBPase pathway in cystathionine γ-lyase knockout mice[J].PLoS One,2011,6:e29592.
  • 7Berlanga J,Cibrian D,Guillen I,et al.Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds[J].Clin Sci (Lond),2005,109:83-95.
  • 8Wang H,Meng QH,Gordon JR,et al.Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus[J].Clin Biochem,2007,40:1232-1239.
  • 9Green K,Brand MD,Murphy MP.Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes[J].Diabetes,2004,53 Suppl 1:S110-118.
  • 10Rosca MG,Monnier VM,Szweda LI,et al.Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal[J].Am J Physiol Renal Physiol,2002,283:F52-59.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部